Cookies management by TermsFeed Cookie Consent
Recent News

Press Releases

23-11-2021 15:25

Photo Album - Foreign Affairs Minister – General Affairs Council of the EU

The Minister of Foreign Affairs, Mr Nikos Christodoulides, at the General Affairs Council of the EU, in Brussels.

23-11-2021 14:20

Rapid antigen testing units – 24 November 2021

Based on the decisions of the Council of Ministers, and aiming at the suppression of the dispersion of the virus SARS-CoV-2, as of the 18th of October, in places where SafePass is required, individuals aged 12 and above must hold one of the following:1.   Certificate of full vaccination.2.   Proof that they have been infected with COVID-19 during the last six months.3.   Certificate of a PCR negative test or a negative rapid antigen test result, valid for 72 hours.According to the Ministe...

23-11-2021 11:19

Photo Album - Interior Minister – Cypriot community in London

Τhe Minister of Interior, Mr Nicos Nouris, at the Cypriot community in London.

23-11-2021 10:28

EMA evaluating data on booster dose of COVID-19 Vaccine Janssen

EMA has started evaluating an application for the use of a booster dose of COVID-19 Vaccine Janssen to be given at least two months after the first dose to people aged 18 years and older.EMA’s human medicines committee (CHMP) will carry out an accelerated assessment of data submitted by the company that markets the vaccine. These data include results from more than 14,000 adults who received a second dose of COVID-19 Vaccine Janssen or placebo (a dummy treatment) two months after the initial...

23-11-2021 08:38

Lemesos City Centre Post Office closed

The Cyprus Post announces that today, 23 November 2021, Lemesos City Centre Post Office will remain closed for disinfection, due to a Covid-19 incident.(MV/ECHR)

22-11-2021 21:41

Photo Album - PoR – Prisons Department theatrical performance

The President of the Republic, Mr Nicos Anastasiades, at the theatrical performance of the Prisons Department at Latsia Municipal Theatre.

22-11-2021 14:46

Epidemiological risk assessment of countries concerning COVID-19, dated 22/11/2021

Following a decision of the Council of Ministers, on 18 February 2021, regarding the Action Plan for the gradual resumption of flights and the re-opening of airports, the Epidemiological Monitoring Unit of the Ministry of Health has made a re-evaluation of the epidemiological situation in various countries as regards COVID-19.The categorization for the countries of the European Union and the European Economic Area (Iceland, Liechtenstein, Norway) as well as Switzerland, in the Green, Orange ...

22-11-2021 14:01

Rapid antigen testing units – 23 November 2021

Based on the decisions of the Council of Ministers, and aiming at the suppression of the dispersion of the virus SARS-CoV-2, as of the 18th of October, in places where SafePass is required, individuals aged 12 and above must hold one of the following:1.   Certificate of full vaccination.2.   Proof that they have been infected with COVID-19 during the last six months.3.   Certificate of a PCR negative test or a negative rapid antigen test result, valid for 72 hours.According to the Ministe...

22-11-2021 13:35

Turnover Value Index of Transport and Storage: 3rd quarter 2021

Annual Change +27,6%  The Turnover Value Index of Transport and Storage for the third quarter of 2021 reached 101,6 units (base year 2015=100), recording an increase of 27,6% compared to the corresponding quarter of 2020.  By economic activity, increases relative to the third quarter of the previous year were observed in air transport by 95,2%, in water transport by 91,1%, in warehousing and support activities for transportation by 26,6%, in land transport by 23,0% and in postal and courier...

22-11-2021 12:13

EMA starts review of Paxlovid for treating patients with COVID-19

EMA is reviewing currently available data on the use of Paxlovid (PF-07321332/ritonavir), an oral treatment for COVID-19 developed by Pfizer. EMA is starting this review to support national authorities who may decide on its early use for COVID-19, for example in emergency use settings, prior to marketing authorisation.EMA’s human medicines committee (CHMP) will look at data from a study comparing the effect of Paxlovid with that of a dummy treatment (placebo) in non-hospitalised patients wit...

Archive